BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 34411603)

  • 41. Microbiota-Gut-Brain Axis in Neurological Disorders: From Leaky Barriers Microanatomical Changes to Biochemical Processes.
    Neri I; Boschetti E; Follo MY; De Giorgio R; Cocco LI; Manzoli L; Ratti S
    Mini Rev Med Chem; 2023; 23(3):307-319. PubMed ID: 35733303
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of Blood-Brain Barrier in Alzheimer's Disease.
    Cai Z; Qiao PF; Wan CQ; Cai M; Zhou NK; Li Q
    J Alzheimers Dis; 2018; 63(4):1223-1234. PubMed ID: 29782323
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Brain-Gut-Microbiota Axis in Alzheimer's Disease.
    Kowalski K; Mulak A
    J Neurogastroenterol Motil; 2019 Jan; 25(1):48-60. PubMed ID: 30646475
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Role of the Microbiota-Gut-Brain Axis in the Development of Alzheimer's Disease.
    Wiatrak B; Balon K; Jawień P; Bednarz D; Jęśkowiak I; Szeląg A
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563253
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dietary neoagarotetraose extends lifespan and impedes brain aging in mice via regulation of microbiota-gut-brain axis.
    Li T; Yang S; Liu X; Li Y; Gu Z; Jiang Z
    J Adv Res; 2023 Oct; 52():119-134. PubMed ID: 37085001
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gut dysbiosis in stroke and its implications on Alzheimer's disease-like cognitive dysfunction.
    Cho J; Park YJ; Gonzales-Portillo B; Saft M; Cozene B; Sadanandan N; Borlongan CV
    CNS Neurosci Ther; 2021 May; 27(5):505-514. PubMed ID: 33464726
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of Pesticide Residues on the Gut-Microbiota-Blood-Brain Barrier Axis: A Narrative Review.
    Abou Diwan M; Lahimer M; Bach V; Gosselet F; Khorsi-Cauet H; Candela P
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047120
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blood-brain barrier integrity in the pathogenesis of Alzheimer's disease.
    Huang Z; Wong LW; Su Y; Huang X; Wang N; Chen H; Yi C
    Front Neuroendocrinol; 2020 Oct; 59():100857. PubMed ID: 32781194
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alzheimer's disease drug development and the problem of the blood-brain barrier.
    Pardridge WM
    Alzheimers Dement; 2009 Sep; 5(5):427-32. PubMed ID: 19751922
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of chronic noise exposure on the microbiome-gut-brain axis in senescence-accelerated prone mice: implications for Alzheimer's disease.
    Cui B; Su D; Li W; She X; Zhang M; Wang R; Zhai Q
    J Neuroinflammation; 2018 Jun; 15(1):190. PubMed ID: 29933742
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Blood Brain Barrier and its Role in Alzheimer's Therapy: An Overview.
    Jakki SL; Senthil V; Yasam VR; Chandrasekar MJN; Vijayaraghavan C
    Curr Drug Targets; 2018; 19(2):155-169. PubMed ID: 28606049
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microbiota-gut-brain axis in the Alzheimer's disease pathology - an overview.
    Giridharan VV; Barichello De Quevedo CE; Petronilho F
    Neurosci Res; 2022 Aug; 181():17-21. PubMed ID: 35577241
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impaired blood-brain barrier in the microbiota-gut-brain axis: Potential role of bipolar susceptibility gene TRANK1.
    Lai J; Jiang J; Zhang P; Xi C; Wu L; Gao X; Fu Y; Zhang D; Chen Y; Huang H; Zhu Y; Hu S
    J Cell Mol Med; 2021 Jul; 25(14):6463-6469. PubMed ID: 34014031
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship Between the Gut Microbiota and Alzheimer's Disease: A Systematic Review.
    González Cordero EM; Cuevas-Budhart MA; Pérez Morán D; Trejo Villeda MA; Gomez-Del-Pulgar Gª-Madrid M
    J Alzheimers Dis; 2022; 87(2):519-528. PubMed ID: 35367961
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug delivery to the brain in Alzheimer's disease: consideration of the blood-brain barrier.
    Banks WA
    Adv Drug Deliv Rev; 2012 May; 64(7):629-39. PubMed ID: 22202501
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Meta-Analysis of Methamphetamine Modulation on Amyloid Precursor Protein through HMGB1 in Alzheimer's Disease.
    Alabed S; Zhou H; Sariyer IK; Chang SL
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946401
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protection against Alzheimer's disease by luteolin: Role of brain glucose regulation, anti-inflammatory activity, and the gut microbiota-liver-brain axis.
    Daily JW; Kang S; Park S
    Biofactors; 2021 Mar; 47(2):218-231. PubMed ID: 33347668
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microbiota-gut-brain axis and toll-like receptors in Alzheimer's disease.
    Lin C; Zhao S; Zhu Y; Fan Z; Wang J; Zhang B; Chen Y
    Comput Struct Biotechnol J; 2019; 17():1309-1317. PubMed ID: 31921396
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Associations Between Gut Microbiota and Alzheimer's Disease: Current Evidences and Future Therapeutic and Diagnostic Perspectives.
    Shen L; Ji HF
    J Alzheimers Dis; 2019; 68(1):25-31. PubMed ID: 30814354
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alzheimer's disease and gastrointestinal microbiota; impact of
    Doulberis M; Kotronis G; Gialamprinou D; Polyzos SA; Papaefthymiou A; Katsinelos P; Kountouras J
    Int J Neurosci; 2021 Mar; 131(3):289-301. PubMed ID: 32125206
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.